CPT® Code 86652

Official Description

Antibody; encephalitis, Eastern equine

Common Language Description

The CPT® Code 86652 refers to a laboratory test specifically designed to measure antibodies related to Eastern equine encephalitis (EEE) in serum and/or cerebrospinal fluid (CSF). Eastern equine encephalitis is classified within the alphavirus group of arboviruses, which are primarily transmitted through mosquito bites and can also involve wild birds as hosts. This virus is predominantly found in the Eastern and Gulf states of the United States, where it has a low prevalence among human populations. However, outbreaks tend to peak during the summer and early fall months. The clinical presentation of EEE is generally mild, with common symptoms including headache and fever. It is important to note that central nervous system symptoms are observed in only a minority of individuals infected with the virus. Children are particularly vulnerable and often exhibit more severe manifestations of the disease. The laboratory test detects specific antibodies to EEE, with IgG antibody titers indicating either a current or past infection, while IgM antibodies suggest a current or recent infection. It is crucial to recognize that both IgG and IgM antibodies may show cross-reactivity with antibodies from Western equine encephalitis (WEE) infection, which can complicate the interpretation of results. When evaluating symptomatic patients, healthcare providers should consider the patient's travel history, along with relevant medical and epidemiological data, especially if the virus has not been isolated in the laboratory. The testing process involves obtaining a blood sample through a separately reportable venipuncture, while CSF is collected via a separately reportable lumbar puncture. The serum and CSF samples are then analyzed using semi-quantitative indirect fluorescent antibody or immunofluorescent assay techniques to determine the presence of EEE antibodies.

1. Indications

The laboratory test associated with CPT® Code 86652 is indicated for the evaluation of potential Eastern equine encephalitis (EEE) infection in patients presenting with specific symptoms or risk factors. The following conditions warrant the performance of this test:

Suspected EEE Infection Patients exhibiting symptoms consistent with EEE, such as headache, fever, and central nervous system manifestations, may require testing to confirm or rule out the presence of EEE antibodies.
Recent Travel to Endemic Areas Individuals who have traveled to regions where EEE is known to occur, particularly during peak outbreak seasons, should be tested if they present with relevant symptoms.
Severe Symptoms in Children Given that children may experience more severe signs and symptoms of EEE, testing is particularly indicated in this population when they show clinical signs suggestive of the infection.

2. Procedure

The procedure for testing EEE antibodies involves several critical steps to ensure accurate results. The following outlines the procedural steps associated with CPT® Code 86652:

Step 1: Patient Preparation Prior to sample collection, the healthcare provider should ensure that the patient is adequately informed about the procedure, including the need for blood and CSF samples. This may involve discussing the symptoms and potential risks associated with EEE.
Step 2: Sample Collection Blood is obtained through a venipuncture, which is a separately reportable procedure. The healthcare professional will use a sterile technique to draw blood from a suitable vein, typically in the arm. Additionally, cerebrospinal fluid (CSF) is collected via a lumbar puncture, another separately reportable procedure. This involves inserting a needle into the lower back to access the spinal canal and withdraw CSF for analysis.
Step 3: Laboratory Analysis Once the serum and CSF samples are collected, they are sent to a laboratory for testing. The laboratory utilizes semi-quantitative indirect fluorescent antibody or immunofluorescent assay techniques to detect the presence of IgG and IgM antibodies specific to EEE. This analysis helps determine whether the patient has a current or past infection.

3. Post-Procedure

After the procedure, patients may experience some discomfort at the venipuncture or lumbar puncture sites, which is typically mild and resolves quickly. It is important for healthcare providers to monitor patients for any adverse reactions following the lumbar puncture, such as headache or back pain. Patients should be advised to rest and hydrate adequately after the procedure. The results of the antibody tests will be interpreted in conjunction with the patient's clinical presentation and history, and follow-up care may be necessary based on the findings. If EEE infection is confirmed, appropriate management and treatment options should be discussed with the patient.

Short Descr	ENCEPHALTIS EAST EQNE ANBDY
Medium Descr	ANTIBODY ENCEPHALITIS EASTERN EQUINE
Long Descr	Antibody; encephalitis, Eastern equine
Status Code	Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days	XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC)	9 - Not Applicable
Multiple Procedures (51)	9 - Concept does not apply.
Bilateral Surgery (50)	9 - Concept does not apply.
Physician Supervisions	09 - Concept does not apply.
Assistant Surgeon (80, 82)	9 - Concept does not apply.
Co-Surgeons (62)	9 - Concept does not apply.
Team Surgery (66)	9 - Concept does not apply.
Diagnostic Imaging Family	99 - Concept Does Not Apply
CLIA Waived (QW)	No
APC Status Indicator	Conditionally packaged laboratory tests
Type of Service (TOS)	5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS)	T1H - Lab tests - other (non-Medicare fee schedule)
MUE	2
CCS Clinical Classification	235 - Other Laboratory

90	Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
91	Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
XU	Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service